J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2006

Papers In Press, published online ahead of print October 19, 2005
J. Lipid Res., doi:10.1194/jlr.M500215-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M500215-JLR200v1
47/1/42    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergheim, I.
Right arrow Articles by Stange, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergheim, I.
Right arrow Articles by Stange, E. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on May 27, 2005
Revised on October 12, 2005
Accepted on October 18, 2005

Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers

Ina Bergheim, Simone Harsch, Oliver Mueller, Silke Schimmel, Peter Fritz, and Eduard F. Stange

Abteilung Innere Medizin 1 , Robert-Bosch-Krankenhaus , Stuttgart D-70376

Corresponding Author: eduard.stange{at}rbk.de

While a cholesterol supersaturation of gallbladder bile has been identified as the underlying pathophysiologic defect the molecular pathomechnism of gallstone formation in humans remains poorly understood. A deficiency of the apical sodium-dependent bile acid transporter (ASBT) and ileal lipid binding protein (ILBP) in the small intestine may result in bile acid loss into the colon and might promote gallstone formation by reducing the bile acid pool and increasing the amount of hydrophobic bile salts. To test this hypothesis protein levels and mRNA expression of ASBT and ILBP were assessed in ileal mucosa biopsies of female gallstone carriers and controls. Neither ASBT nor ILBP levels differed significantly between gallstone carriers and controls. However, when sub-grouping study participants by body-weight, ASBT and ILBP protein were 48% and 67% lower in normal weight gallstone carriers than in controls (p<0.05); similar differences were found for mRNA expression levels. The loss of bile transporters in female normal weight gallstone carriers was coupled with a reduction of protein levels of hepatic nuclear factor 1 alpha (HNF1alpha ) and farnesoid X-receptor (FXR). In conclusion, in normal weight female gallstone carriers the decreased expression of ileal bile acid transporters may form a molecular basis for gallstone formation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
O. Renner, S. Harsch, A. Strohmeyer, S. Schimmel, and E. F. Stange
Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease
J. Lipid Res., September 1, 2008; 49(9): 2045 - 2054.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.